#LCSM Chat Topic 07-Oct-2021: Best in Show–Lung Cancer Highlights from #WCLC21 & #ESMO21
Two premier oncology professional organizations, ESMO (European Society for Medical Oncology) and IASLC (International Association for the Study of Lung Cancer), held meetings in September. On Thursday, October 7, at 8 pm Eastern Time (5 pm Pacific), #LCSM Chat will discuss major lung cancer findings from IASLC 2021 World Conference on Lung Cancer (#WCLC21) and the ESMO 2021 Annual Meeting (#ESMO21). We will examine #WCLC21 and #ESMO21 presentations that could have major impacts on lung cancer clinical care, and why these are important to the lung cancer community. Our moderator Charu Aggarwal… Read More
#LCSM Chat Topic 5/7/2020: #COVID19 testing and #lungcancer: Where we stand today
The COVID-19 pandemic is scary, and the situation continues to evolve. Lung cancer patients and families may have little understanding of COVID-19 testing or how it may affect patient care. And there is plenty of confusion out there! For our next chat, “COVID-19 testing and lung cancer: Where we stand today,” we will discuss these concerns with pulmonary pathologists and molecular pathologists, who are on the cutting edge of COVID-19 test development and use. Please join #LCSM Chat Thursday, May 7, 2020, at 8 pm Eastern time (5 pm Pacific) to discuss… Read More
#LCSM Chat Topic 4/2/2020: #COVID19 and #LungCancer
It seems that the world has turned upside down. At the time I write this, there have been almost 550,00 cases of COVID-19 confirmed in the world and over 85,000 in the US. Here in New York City there have been over 23,000 cases and 365 deaths as of March 27th (https://coronavirus.jhu.edu/map.html). The pandemic has placed enormous stress on our health care delivery system. For lung cancer patients, it has affected healthcare providers’ ability to perform tests and radiologic procedures; provide timely diagnosis, staging, and care for early stage patients; and, in… Read More
#LCSM 
You must be logged in to post a comment.